162 related articles for article (PubMed ID: 32802842)
1. A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma.
Perumal K; Mun KS; Yap NY; Razack AHA; Gobe GC; Ong TA; Kuppusamy S; Rajandram R
Biomed Res Int; 2020; 2020():3682086. PubMed ID: 32802842
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
3. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
5. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance.
Rajandram R; Yap NY; Pailoor J; Razack AH; Ng KL; Ong TA; Morais C; Gobe GC
Pathology; 2014 Oct; 46(6):518-22. PubMed ID: 25158810
[TBL] [Abstract][Full Text] [Related]
7. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
9. The significance of CD14 in clear cell renal cell carcinoma progression and survival prognosis.
Yap NY; Ong TA; Pailoor J; Gobe G; Rajandram R
Biomarkers; 2023 Feb; 28(1):24-31. PubMed ID: 36315054
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
12. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
14. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
15. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
[TBL] [Abstract][Full Text] [Related]
16. Expression of PGAM1 in renal clear cell carcinoma and its clinical significance.
Li C; Shu F; Lei B; Lv D; Zhang S; Mao X
Int J Clin Exp Pathol; 2015; 8(8):9410-5. PubMed ID: 26464696
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.
Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R
Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170
[TBL] [Abstract][Full Text] [Related]
18. Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Ren W; Xue B; Chen M; Liu L; Zu X
Clin Genitourin Cancer; 2019 Jun; 17(3):e433-e439. PubMed ID: 30773312
[TBL] [Abstract][Full Text] [Related]
19. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
20. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]